796
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Synthesis and characterization of phenolic Mannich bases and effects of these compounds on human carbonic anhydrase isozymes I and II

, , , &
Pages 337-342 | Received 28 Mar 2012, Accepted 11 May 2012, Published online: 20 Sep 2012

References

  • Lipscomb WN, Sträter N. Recent Advances in Zinc Enzymology. Chem Rev 1996;96:2375–2434.
  • Gülçin İ, Beydemir Ş, Büyükokuroğlu ME. In vitro and in vivo effects of dantrolene on carbonic anhydrase enzyme activities. Biol Pharm Bull 2004;27:613–616
  • Gülçin İ, Alici HA, Cesur M. Determination of in vitroantioxidant and radical scavenging activities of propofol. Chem Pharm Bull 2005;53:281–285
  • Gülçin İ, Büyükokuroglu ME, Oktay M, Küfrevioglu Öİ. On the in vitro antioxidant properties of melatonin. J Pineal Res 2002;33:167–171.
  • Hilvo M, Baranauskiene L, Salzano AM, Scaloni A, Matulis D, Innocenti A et al. Biochemical characterization of CA IX, one of the most active carbonic anhydrase isozymes. J Biol Chem 2008;283:27799–27809.
  • Di Fiore A, Scozzafava A, Winum JY, Montero JL, Pedone C, Supuran CT et al. Carbonic anhydrase inhibitors: binding of an antiglaucoma glycosyl-sulfanilamide derivative to human isoform II and its consequences for the drug design of enzyme inhibitors incorporating sugar moieties. Bioorg Med Chem Lett 2007;17:1726–1731.
  • Innocenti A, Vullo D, Pastorek J, Scozzafava A, Pastorekova S, Nishimori I et al. Carbonic anhydrase inhibitors. Inhibition of transmembrane isozymes XII (cancer-associated) and XIV with anions. Bioorg Med Chem Lett 2007;17:1532–1537.
  • Winum JY, Thiry A, Cheikh KE, Dogné JM, Montero JL, Vullo D et al. Carbonic anhydrase inhibitors. Inhibition of isoforms I, II, IV, VA, VII, IX, and XIV with sulfonamides incorporating fructopyranose-thioureido tails. Bioorg Med Chem Lett 2007;17:2685–2691.
  • Scozzafava A, Banciu MD, Popescu A, Supuran CT. Carbonic anhydrase inhibitors: inhibition of isozymes I, II and IV by sulfamide and sulfamic acid derivatives. J Enzym Inhib 2000;15:443–453.
  • Schuman JS. Antiglaucoma medications: a review of safety and tolerability issues related to their use. Clin Ther 2000;22:167–208.
  • Wilkinson BL, Bornaghi LF, Houston TA, Innocenti A, Vullo D, Supuran CT et al. Inhibition of membrane-associated carbonic anhydrase isozymes IX, XII and XIV with a library of glycoconjugate benzenesulfonamides. Bioorg Med Chem Lett 2007;17:987–992.
  • Santos MA, Marques S, Vullo D, Innocenti A, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors: inhibition of cytosolic/tumor-associated isoforms I, II, and IX with iminodiacetic carboxylates/hydroxamates also incorporating benzenesulfonamide moieties. Bioorg Med Chem Lett 2007;17:1538–1543.
  • Ilies M, Scozzafava A, Supuran CT. Carbonic anhydrase activators. In: Carbonic Anhydrase – Its Inhibitors and Activators; Supuran CT, Scozzafava A, Conway J. Eds.Boca Raton; CRC Press:, 2004; pp 317–352;
  • Temperini C, Scozzafava A, Supuran CT. Drug design studies of carbonic anhydrase activators. In Drug Design of Zinc-Enzyme Inhibitors – Functional, Structural, and Disease Applications; Supuran CT, Winum JY. Eds.; Wiley: Hoboken, 2009; pp 473–486.
  • Briganti F, Mangani S, Orioli P, Scozzafava A, Vernaglione G, Supuran CT. Carbonic anhydrase activators: X-ray crystallographic and spectroscopic investigations for the interaction of isozymes I and II with histamine. Biochemistry 1997;36:10384–10392.
  • Becker HM, Klier M, Schüler C, McKenna R, Deitmer JW. Intramolecular proton shuttle supports not only catalytic but also noncatalytic function of carbonic anhydrase II. Proc Natl Acad Sci USA 2011;108:3071–3076.
  • Elder I, Tu C, Ming LJ, McKenna R, Silverman DN. Proton transfer from exogenous donors in catalysis by human carbonic anhydrase II. Arch Biochem Biophys 2005;437:106–114;
  • Tripp BC, Ferry JG. A structure-function study of a proton transport pathway in the gamma-class carbonic anhydrase from Methanosarcina thermophila Biochemistry. 2000;39:9232–9240.
  • Dave K, Ilies MA, Scozzafava A, Temperini C, Vullo D, Supuran CT. An inhibitor-like binding mode of a carbonic anhydrase activator within the active site of isoform II. Bioorg Med Chem Lett 2011;21:2764–2768
  • Dave K, Scozzafava A, Vullo D, Supuran CT, Ilies MA. Pyridinium derivatives of histamine are potent activators of cytosolic carbonic anhydrase isoforms I, II and VII: solution and crystallographic studies. Org Biomol Chem 2011;9:2790–2800.
  • Pocker Y, Deits TL. Effects of pH on anionic inhibition of carbonic anhydrase activities. J Am Chem Soc 1982; 104:2424–2434.
  • Tibell L, Forsman C, Simonsson I, Lindskog S. Anion inhibition of CO2 hydration catalyzed by human carbonic anhydrase II. Mechanistic implications. Biochim Biophys Acta 1984;789:302–310.
  • Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008;7:168–181.
  • Supuran CT, Scozzafava A. Activation of carbonic anhydrase isozymes. In: The Carbonic Anhydrases—New Horizons; Chegwidden WR, Carter N, Edwards Y. Eds.; Basel, Switzerland Birkhauser Verlag: 2000; pp 197–219.
  • Temperini C, Scozzafava A, Puccetti L, Supuran CT. Carbonic anhydrase activators: X-ray crystal structure of the adduct of human isozyme II with L-histidine as a platform for the design of stronger activators. Bioorg Med Chem Lett 2005;15:5136–5141.
  • Temperini C, Scozzafava A, Vullo D, Supuran CT. Carbonic anhydrase activators. Activation of isoforms I, II, IV, VA, VII, and XIV with L- and D-phenylalanine and crystallographic analysis of their adducts with isozyme II: stereospecific recognition within the active site of an enzyme and its consequences for the drug design. J Med Chem 2006;49:3019–3027.
  • Temperini C, Innocenti A, Scozzafava A, Mastrolorenzo A, Supuran CT. Carbonic anhydrase activators: L-Adrenaline plugs the active site entrance of isozyme II, activating better isoforms I, IV, VA, VII, and XIV. Bioorg Med Chem Lett 2007;17:628–635.
  • Parkkila S, Vullo D, Puccetti L, Parkkila AK, Scozzafava A, Supuran CT. Carbonic anhydrase activators: activation of isozyme XIII with amino acids and amines. Bioorg Med Chem Lett 2006;16:3955–3959.
  • Vullo D, Nishimori I, Innocenti A, Scozzafava A, Supuran CT. Carbonic anhydrase activators: an activation study of the human mitochondrial isoforms VA and VB with amino acids and amines. Bioorg Med Chem Lett 2007;17:1336–1340.
  • Vullo D, Innocenti A, Nishimori I, Scozzafava A, Kaila K, Supuran CT. Carbonic anhydrase activators: activation of the human isoforms VII (cytosolic) and XIV (transmembrane) with amino acids and amines. Bioorg Med Chem Lett 2007;17:4107–4112.
  • Nishimori I, Onishi S, Vullo D, Innocenti A, Scozzafava A, Supuran CT. Carbonic anhydrase activators: the first activation study of the human secretory isoform VI with amino acids and amines. Bioorg Med Chem 2007;15:5351–5357.
  • Innocenti A, Vullo D, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors: interactions of phenols with the 12 catalytically active mammalian isoforms (CA I-XIV). Bioorg Med Chem Lett 2008;18:1583–1587.
  • Innocenti A, Vullo D, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors: inhibition of mammalian isoforms I-XIV with a series of substituted phenols including paracetamol and salicylic acid. Bioorg Med Chem 2008;16:7424–7428
  • Innocenti A, Hilvo M, Scozzafava A, Parkkila S, Supuran CT. Carbonic anhydrase inhibitors: Inhibition of the new membrane-associated isoform XV with phenols. Bioorg Med Chem Lett 2008;18:3593–3596
  • Bayram E, Senturk M, Kufrevioglu OI, Supuran CT. In vitro inhibition of salicylic acid derivatives on human cytosolic carbonic anhydrase isozymes I and II. Bioorg Med Chem 2008;16:9101–9105.
  • Sentürk M, Gülçin I, Dastan A, Küfrevioglu OI, Supuran CT. Carbonic anhydrase inhibitors. Inhibition of human erythrocyte isozymes I and II with a series of antioxidant phenols. Bioorg Med Chem 2009;17:3207–3211.
  • Joshi S, Khosla N, Khare D, Sharda R. Synthesis and in vitro study of novel Mannich bases as antibacterial agents. Bioorg Med Chem Lett 2005;15:221–226.
  • Joshi S, Khosla N, Tiwari P. In vitro study of some medicinally important Mannich bases derived from antitubercular agent. Bioorg Med Chem 2004;12:571–576.
  • Bilgiç S, Bilgiç O, Büyükkıdan B, Gündüz M. Synthesis of chromans from the reaction of o-quinone methide precursor with substituted styrenes. J Chem Res 2007; 2007:76–79.
  • Arslan B, Nalbantoğlu B, Demir N, Özdemir H, Küfrevioğlu Öİ. A new method for the purification of carbonic anhydrase isozymes by affinity chromatography. Trop J Med Sci 1996;26:163.
  • Rickli EE, Ghazanfar SA, Gibbons BH, Edsall JT. Carbonic anhydrases from human erythrocytes. Preparation and properties of two enzymes. J Biol Chem 1964;239:1065–1078.
  • Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248–254.
  • Laemmli DK. Clevage of structural proteins during in assembly of the head of bacteriophage T4. Nature 1970;227:680.
  • Wilbur KM, Anderson NG. Electrometric and colorimetric determination of carbonic anhydrase. J Biol Chem 1948;176:147–154.
  • Verpoorte JA, Mehta S, Edsall JT. Esterase activities of human carbonic anhydrases B and C. J Biol Chem 1967;242:4221–4229.
  • Innocenti A, Scozzafava A, Parkkila S, Puccetti L, De Simone G, Supuran CT. Investigations of the esterase, phosphatase, and sulfatase activities of the cytosolic mammalian carbonic anhydrase isoforms I, II, and XIII with 4-nitrophenyl esters as substrates. Bioorg Med Chem Lett 2008;18:2267–2271.
  • Landolfi C, Marchetti M, Ciocci G, Milanese C. Development and pharmacological characterization of a modified procedure for the measurement of carbonic anhydrase activity. J Pharmacol Toxicol Methods 1997;38:169–172.
  • Bülbül M, Hisar O, Beydemir S, Ciftçi M, Küfrevioglu OI. The in vitro and in vivo inhibitory effects of some sulfonamide derivatives on rainbow trout (Oncorhynchus mykiss) erythrocyte carbonic anhydrase activity. J Enzyme Inhib Med Chem 2003;18:371–375.
  • Ciftçi M, Bülbül M, Gül M, Gümüstekin K, Dane S, Süleyman H. Effects of nicotine and vitamin E on carbonic anhydrase activity in some rat tissues in vivo and in vitro. J Enzyme Inhib Med Chem 2005;20:103–108.
  • Hisar O, Beydemir Ş, Bülbül M, Yanık T. Kinetic properties of carbonic anhydrase purified from gills of rainbow trout (Oncorhynchus mykiss). J Appl Anim Res 2006;30:185.
  • Winum JY, Cecchi A, Montero JL, Innocenti A, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors. Synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with boron-containing sulfonamides, sulfamides, and sulfamates: toward agents for boron neutron capture therapy of hypoxic tumors. Bioorg Med Chem Lett 2005;15:3302–3306.
  • Szady-Chelmieniecka A, Rozwadowski Z, Dziembowska T, Grech E, Wojciechowski G, Brzezinski B. Intramolecular hydrogen bonds in 3-diethylaminomethyl-5-R-salicylic aldehydes. J Mol Stru 2000;520:39.
  • Chi KW, Ahn YS, Shim KT, Park TH, Ahn JS. One-pot synthesis of Mannich base using hyd aromatic rings and secondary amines. Bull Korean Chem Soc 1999;20:973.
  • Palaniappan S, John A, Amarnath CA, Rao VJ. Mannich-type reaction in solvent free condition using reusable polyaniline catalyst Journal of Molecular Catalysis A: Chemical 2004;218: 47.
  • Yenikaya C, Poyraz M, Sarı M, Demirci F, İlkimen H, Büyürkgüngör O. Synthesis, characterization and biological evaluation of a novel Cu(II) complex with the mixed ligands 2,6-pyridinedicarboxylic acid and 2-aminopyridine. Polyhedron 2009;28:3526.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.